Literature DB >> 23417424

Hepatic growth hormone resistance after acute injury.

Ryan M Corrick1, Li Li, Stuart J Frank, Joseph L Messina.   

Abstract

Severe injury and infection are often followed by accelerated protein catabolism and acute insulin resistance. This results in several effects that complicate and prolong recovery, including weakness, immobility, impaired wound healing, and organ dysfunction. Recent studies have demonstrated the development of GH resistance during severe inflammation, providing a potential mechanism for the protein loss that follows injury and infection. To understand this GH resistance, we recently developed a murine model of acute injury. Mice were subjected to soft-tissue injury, alone or combined with hemorrhage, and injected iv with GH 30, 60, or 90 minutes later. Hepatic GH signaling was measured via Western analysis. GH-induced signal transducer and activator of transcription 5 phosphorylation was decreased immediately after completion of the trauma procedure, and at 30 and 60 minutes, but further decreased by 90 minutes after trauma. Combined trauma and hemorrhage resulted in severely decreased GH-induced signal transducer and activator of transcription 5 phosphorylation compared with trauma alone, and this was true at all time points studied. Western analysis revealed an apparent decrease in the molecular weight of the hepatic GH receptor (GHR) after trauma and hemorrhage, but not trauma alone. Additional studies determined that the hemorrhage-induced decrease in receptor size was not due to changes in GHR N-linked glycosylation. These results suggest that GH sensitivity is rapidly impaired after acute injury and that trauma combined with hemorrhage results in a more severe form of GH resistance resulting from alteration or inactivation of hepatic GHR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23417424      PMCID: PMC3602625          DOI: 10.1210/en.2012-2134

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  53 in total

Review 1.  Dangers of growth hormone therapy in critically ill patients.

Authors:  Esko Ruokonen; Jukka Takala
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-03       Impact factor: 4.294

2.  Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway.

Authors:  S Ji; R Guan; S J Frank; J L Messina
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

3.  Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis.

Authors:  Y Zhang; R Guan; J Jiang; J J Kopchick; R A Black; G Baumann; S J Frank
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

4.  Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.

Authors:  S H Park; H Yamashita; H Rui; D J Waxman
Journal:  Mol Endocrinol       Date:  2001-12

5.  Hemorrhage induces the rapid development of hepatic insulin resistance.

Authors:  Yuchen Ma; Ping Wang; Joachim F Kuebler; Irshad H Chaudry; Joseph L Messina
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-09-25       Impact factor: 4.052

6.  STAT5b is required for GH-induced liver IGF-I gene expression.

Authors:  H W Davey; T Xie; M J McLachlan; R J Wilkins; D J Waxman; D R Grattan
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

7.  Impairment of liver GH receptor signaling by fasting.

Authors:  Váronique Beauloye; Bertrand Willems; Virginie de Coninck; Stuart J Frank; Marc Edery; Jean-Paul Thissen
Journal:  Endocrinology       Date:  2002-03       Impact factor: 4.736

8.  Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis.

Authors:  Gladys Yumet; Margaret L Shumate; Patrick Bryant; Cheng-Mao Lin; Charles H Lang; Robert N Cooney
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-09       Impact factor: 4.310

9.  Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation.

Authors:  Ly Q Hong-Brown; C Randell Brown; Robert N Cooney; Robert A Frost; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-03-18       Impact factor: 4.310

10.  Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.

Authors:  Lee A Denson; Matthew A Held; Ram K Menon; Stuart J Frank; Albert F Parlow; Dodie L Arnold
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-01-02       Impact factor: 4.052

View more
  3 in total

1.  Multiomics analysis profile acute liver injury module clusters to compare the therapeutic efficacy of bifendate and muaddil sapra.

Authors:  Ainiwaer Talifu; Refuhati Saimaiti; Yusufu Maitinuer; Geyu Liu; Miernisha Abudureyimu; Xuelei Xin
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

Review 2.  Interaction of the endocrine system with inflammation: a function of energy and volume regulation.

Authors:  Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2014-02-13       Impact factor: 5.156

3.  Immunogenomics reveal molecular circuits of diclofenac induced liver injury in mice.

Authors:  Eun-Hee Lee; Jung-Hwa Oh; Saravanakumar Selvaraj; Se-Myo Park; Mi-Sun Choi; Reinhard Spanel; Seokjoo Yoon; Jürgen Borlak
Journal:  Oncotarget       Date:  2016-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.